Saudi Arabia Contract Manufacturing Organizations Market to grow with a CAGR of 8.62%
Increasing
healthcare infrastructure and a supportive regulatory environment are the major
drivers for the Saudi Arabia Contract Manufacturing Organizations Market.
According
to TechSci Research report, “Saudi Arabia Contract Manufacturing
Organizations Market Industry Size, Share, Trends, Competition, Opportunity and
Forecast, 2018-2028”, Saudi
Arabia Contract Manufacturing Organizations Market is anticipated to witness an
impressive growth in the forecast period with a CAGR of 8.62% through
2028. This can be due to collaborations
and partnerships among leading companies with a diverse approach to merge the
expertise of individual companies and to strengthen their position in the
market.
The
growth of the pharmaceutical industry is a significant driver for the
increasing demand for Contract Manufacturing Organizations (CMOs). The
pharmaceutical industry invests heavily in research and development (R&D)
to discover and develop new drugs, therapies, and medical innovations. As these
new products move through the R&D pipeline, they often require specialized
manufacturing capabilities, which CMOs can provide. Before new drugs can be
brought to market, they must undergo extensive clinical trials. CMOs play a
critical role in producing the necessary quantities of investigational drugs
and managing the manufacturing aspect of clinical trials. Once a new drug
receives regulatory approval, pharmaceutical companies often require
large-scale manufacturing for commercial production. CMOs offer the capacity
and expertise needed for this scale-up, ensuring a smooth transition from
development to commercialization.
The
pharmaceutical industry encompasses a wide range of products, including small
molecules, biologics, vaccines, sterile products, and more. Each of these
product categories may require different manufacturing processes and expertise,
making CMOs valuable partners. CMOs offer pharmaceutical companies flexibility
in manufacturing, allowing them to adapt quickly to changes in demand and
market conditions. This flexibility is particularly important in the
pharmaceutical industry, which can experience fluctuations in demand.
Browse
over XX market data Figures and spread through XX Pages and an in-depth TOC on
"Saudi Arabia Contract Manufacturing Organizations Market.”
In June 2023, The Public Investment Fund (PIF), Saudi
Arabia's globally recognized investment organization, has recently introduced
Lifera, a contract development and manufacturing organization (CDMO) operating
at a commercial scale. Lifera's establishment is set to bolster the growth of
the domestic bio/pharmaceutical industry, enhance Saudi Arabia's resilience,
and reinforce the nation's status as a leading global hub for pharmaceutical
manufacturing. Lifera's primary focus will be on producing crucial biopharmaceutical
products, encompassing insulins, vaccines, plasma therapeutics, monoclonal
antibodies, cell and gene therapies, as well as innovative small molecules.
Additionally, the company aims to forge strategic partnerships with prominent
local and international enterprises and attract targeted investments to expand
local capacity and fortify domestic manufacturing within this sector. Among
Lifera's core objectives is to facilitate formulation development,
pharmaceutical product development, and manufacturing. The company also plans
to augment testing services for sterile bio/pharmaceutical products.
Quality
control and assurance are vital aspects of the pharmaceutical industry, they
can present challenges in the Saudi Arabia Contract Manufacturing Organizations
(CMOs) market, as they do in the global pharmaceutical manufacturing sector.
The pharmaceutical industry is highly regulated, and CMOs must adhere to a
multitude of local and international regulations. Ensuring compliance with
evolving regulatory standards can be demanding and resource intensive. CMOs may
manufacture a wide range of pharmaceutical products, including small molecules,
biologics, sterile products, and complex therapies. Each product category
requires unique quality control measures and expertise. The validation and
qualification of equipment, processes, and facilities are crucial to
maintaining quality. CMOs need to establish robust validation programs and
ensure ongoing compliance.
Saudi Arabia Contract Manufacturing Organizations
Market is segmented based on Type, End User, and by region.
Based on the Type, Saudi Arabia Contract
Manufacturing Organizations Market is segmented into Active Pharmaceutical
Ingredients (API) Manufacturing, Finished Dosage Formulation (FDF) Development
& Manufacturing, Secondary Packaging. Finished Dosage Formulation (FDF)
Development and Manufacturing is a crucial phase in the pharmaceutical industry
that involves the process of designing, developing, and producing the final
pharmaceutical product in a form that is ready for patient use. This phase is
where active pharmaceutical ingredients (APIs) and other components are
transformed into the specific drug product that patients consume, such as
tablets, capsules, injectables, syrups, or topical creams. The manufacturing
process is validated to ensure that it consistently produces FDFs meeting
predetermined quality and safety criteria. This includes equipment validation,
process validation, and cleaning validation. Selection
of suitable packaging materials and containers to protect the FDF from
environmental factors, moisture, and light, while ensuring patient safety.
Proper labeling is critical to provide
essential information to healthcare providers and patients, including dosage
instructions, warnings, and expiration dates. The FDF is manufactured on a commercial scale to meet market demand.
Large batches are produced in accordance with the validated manufacturing
process.
Based on Region, Northern & Central region held the largest share in the Saudi Arabia
Contract Manufacturing Organizations Market. Being closer to healthcare
facilities and centers of medical excellence can be advantageous for CMOs involved
in pharmaceutical manufacturing, as it allows for easier clinical trials and
collaborations with healthcare providers. The Northern and Central regions
provide better access to local and international markets due to their central
geographical location in Saudi Arabia. This strategic location can enhance a
CMO's market reach and distribution capabilities. The Saudi Arabian government
has been actively promoting economic diversification and investments in the
healthcare and life sciences sectors. As part of these initiatives, they may
provide incentives and support to companies in the Northern and Central
regions. These regions have well-developed transportation and logistics
infrastructure, including road networks, ports, and airports. This facilitates
the movement of raw materials and finished products for CMOs.
Some
of the major companies operating in the Saudi
Arabia Contract Manufacturing Organizations Market include:
- Saudi
Arabian Japanese Pharmaceutical Company (SAJAPHCO)
- AJA
Pharmaceutical Industries Company LTD
- Saudi
Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO)
- Jamjoom
Pharmaceuticals Co.
- Banjara
Holdings
- Batterjee
Pharmaceutical
Download Free Sample Report
Customers can also request 10% free
customization on this report.
“Certain areas, particularly in North
America, are projected to exert significant demand for Contract Manufacturing
Organizations. The growth in the competitive landscape and the presence of
well-established companies in the market, committed to enhance the overall
wellbeing of people each year, are expected to contribute to a remarkable
growth of the Saudi Arabia Contract Manufacturing Organizations Market in the
forecast period," said Mr. Karan Chechi, Research Director with TechSci
Research, a research-based Global management consulting firm.
Saudi Arabia
Contract Manufacturing Organizations Market by Type (Active Pharmaceutical
Ingredients (API) Manufacturing, Finished Dosage Formulation (FDF) Development
& Manufacturing, Secondary Packaging), By End User (Big Pharmaceuticals,
Small and Mid-Size Pharmaceuticals, Generic Pharmaceutical Companies, Others), By
Region, By Competition Forecast
& Opportunities, 2018-2028F has
evaluated the future growth potential of Saudi Arabia Contract
Manufacturing Organizations Market and provides statistics & information on
market size, structure, and future market growth. The report intends to provide
innovative market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in Saudi Arabia
Contract Manufacturing Organizations Market.
Contact Us-
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
M: +13322586602
Email: [email protected]
Website: www.techsciresearch.com